TSPAN7 and plasma cell myeloma: For example, the overexpression of Tspan7 in liver cancer and multiple myeloma cells markedly enhances their metastatic potential [26, 31], whereas exerts an anti-tumor effects in bladder tumors and suppresses the growth of cancer cell through the PTEN/PI3K/Akt signaling pathway [32].